Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Aug;85(2):302–306. doi: 10.1111/j.1365-2249.1991.tb05723.x

Increased spontaneous secretion of IL-6 from B cells of patients with B chronic lymphatic leukaemia (B-CLL) and autoimmunity.

N Lahat 1, E Aghai 1, B Maroun 1, A Kinarty 1, M Quitt 1, P Froom 1
PMCID: PMC1535733  PMID: 1864011

Abstract

We studied B cells from 18 patients with B-CLL, six of them with autoimmune haemolytic anaemia, for spontaneous secretion of IL-6. Our aim was to determine whether the increased incidence of autoimmune disease found in B-CLL patients is associated with enhanced spontaneous IL-6 secretion. IL-6 was measured by the effect of B cell supernatants on the proliferation of an IL-6 dependent plasmacytoma cell line T1165. The highest IL-6 values (7.4 +/- 1.8 U/ml) were measured in supernatants derived on day 3 of culture from lymphocytes of the six patients with B-CLL and concomitant autoimmune disease. The maximal IL-6 values for 10 patients with B-CLL only were 2.8 +/- 0.3 U/ml and for 10 age-matched controls, 0.8 +/- 0.3 U/ml (P less than 0.01, each group compared with the other). We conclude that there is an association between B-CLL, autoimmune disease and the spontaneous in vitro secretion of IL-6. Further studies are needed to determine whether the IL-6 secretion plays a role in the pathogenesis of autoimmune disease in patients with B-CLL.

Full text

PDF
304

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987 Oct;17(10):1411–1416. doi: 10.1002/eji.1830171004. [DOI] [PubMed] [Google Scholar]
  2. Biondi A., Rossi V., Bassan R., Barbui T., Bettoni S., Sironi M., Mantovani A., Rambaldi A. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood. 1989 Apr;73(5):1279–1284. [PubMed] [Google Scholar]
  3. Bussel J., Morell A., Skvaril F. IgG2 deficiency in autoimmune cytopenias. Monogr Allergy. 1986;20:116–118. [PubMed] [Google Scholar]
  4. Carlsson M., Matsson P., Rosén A., Sundström C., Tötterman T. H., Nilsson K. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis. Leukemia. 1988 Nov;2(11):734–744. [PubMed] [Google Scholar]
  5. Chikkappa G., Zarrabi M. H., Tsan M. F. Pure red-cell aplasia in patients with chronic lymphocytic leukemia. Medicine (Baltimore) 1986 Sep;65(5):339–351. doi: 10.1097/00005792-198609000-00006. [DOI] [PubMed] [Google Scholar]
  6. Freeman G. J., Freedman A. S., Rabinowe S. N., Segil J. M., Horowitz J., Rosen K., Whitman J. F., Nadler L. M. Interleukin 6 gene expression in normal and neoplastic B cells. J Clin Invest. 1989 May;83(5):1512–1518. doi: 10.1172/JCI114046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gaspar M. L., Alvarez-Mon M., Gutierrez C. The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings. J Clin Immunol. 1988 Jul;8(4):266–274. doi: 10.1007/BF00916555. [DOI] [PubMed] [Google Scholar]
  8. Gordon J., Guy G., Walker L., Nathan P., Exley R., Clemens M. Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis. Med Oncol Tumor Pharmacother. 1986;3(3-4):269–273. doi: 10.1007/BF02935004. [DOI] [PubMed] [Google Scholar]
  9. Haegeman G., Content J., Volckaert G., Derynck R., Tavernier J., Fiers W. Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem. 1986 Sep 15;159(3):625–632. doi: 10.1111/j.1432-1033.1986.tb09931.x. [DOI] [PubMed] [Google Scholar]
  10. Hivroz C., Grillot-Courvalin C., Brouet J. C., Seligmann M. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Eur J Immunol. 1986 Aug;16(8):1001–1004. doi: 10.1002/eji.1830160821. [DOI] [PubMed] [Google Scholar]
  11. Kawamura N., Muraguchi A., Hori A., Horii Y., Mutsuura S., Hardy R. R., Kikutani H., Kishimoto T. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells. J Clin Invest. 1986 Nov;78(5):1331–1338. doi: 10.1172/JCI112719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988 Mar 3;332(6159):83–85. doi: 10.1038/332083a0. [DOI] [PubMed] [Google Scholar]
  13. Kishimoto T. B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression. J Clin Immunol. 1987 Sep;7(5):343–355. doi: 10.1007/BF00917012. [DOI] [PubMed] [Google Scholar]
  14. Le J., Reis L. F., Vilcek J. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line. Lymphokine Res. 1988 Summer;7(2):99–106. [PubMed] [Google Scholar]
  15. Lemoine F. M., Krystal G., Humphries R. K., Eaves C. J. Autocrine production of pre-B-cell stimulating activity by a variety of transformed murine pre-B-cell lines. Cancer Res. 1988 Nov 15;48(22):6438–6443. [PubMed] [Google Scholar]
  16. Morabito F., Prasthofer E. F., Dunlap N. E., Grossi C. E., Tilden A. B. Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. Blood. 1987 Dec;70(6):1750–1757. [PubMed] [Google Scholar]
  17. Nordan R. P., Neckers L. M., Rudikoff S., Potter M. A growth factor required by plasmacytoma cells in vitro. Curr Top Microbiol Immunol. 1986;132:114–120. doi: 10.1007/978-3-642-71562-4_15. [DOI] [PubMed] [Google Scholar]
  18. Rossi J. F., Commes T., Grenier J., Jourdan M., Chichehian B., Klein B. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type. Am J Hematol. 1988 Dec;29(4):183–188. doi: 10.1002/ajh.2830290402. [DOI] [PubMed] [Google Scholar]
  19. Sauerwein R. W., van der Meer W. G., Aarden L. A. Induction of proliferation of B prolymphocytic leukemia cells by phorbol ester and native or recombinant interferon-gamma. Blood. 1987 Sep;70(3):670–675. [PubMed] [Google Scholar]
  20. Sporn M. B., Roberts A. B. Peptide growth factors are multifunctional. Nature. 1988 Mar 17;332(6161):217–219. doi: 10.1038/332217a0. [DOI] [PubMed] [Google Scholar]
  21. Tanaka Y., Saito K., Shirakawa F., Ota T., Suzuki H., Eto S., Yamashita U. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol. 1988 Nov 1;141(9):3043–3049. [PubMed] [Google Scholar]
  22. Zilberstein A., Ruggieri R., Korn J. H., Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986 Oct;5(10):2529–2537. doi: 10.1002/j.1460-2075.1986.tb04531.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES